Back to results
US 2025/0332195 A1Published application
Chimeric antigen receptor, cell expressing said receptor, pharmaceutical composition including said cell, method for producing said cell, and polynucleotide or vector including nucleotide sequence encoding said chimeric antigen receptor
AssigneeNoile-Immune Biotech, Inc.
InventorsKoji TAMADA, Yukimi SAKODA, Keishi ADACHI
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a chimeric antigen receptor including a target antigen-binding domain, a transmembrane domain, and a signal transduction domain.
Claims16
A chimeric antigen receptor includes a target antigen binding region, a transmembrane region, and a signal transduction region, wherein the transmembrane region includes at its C-terminus a first polypeptide selected from the group consisting of (1a) to (1c) below.
- (1a) a polypeptide consisting of an amino acid sequence in which at least 3 amino acids from the C-terminus are deleted in the amino acid sequence set forth in SEQ ID NO:
- 1;
- (1b) a polypeptide consisting of an amino acid sequence having 85% or more sequence identity to the amino acid sequence of the polypeptide of (1a);
- and
- (1c) a polypeptide consisting of an amino acid sequence in which one or more amino acids are mutated in the amino acid sequence of the polypeptide of (1a).
2 more elements
Dependencies are inferred from the claim text.